Clinical Trial Update: Automate Detection of Sleep Apnea by ApneascanTM [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the Apneascan automated sleep apnea detection device has completed, studying its use in sleep apnea and related arrhythmias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Sleep Apnea

Drugs mentioned

• Apneascan

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Sleep Apnea, Arrhythmias | Phase 4 | Status: COMPLETED